Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-11T03:16:35.029Z.
Calculation as of: 2026-09-11T03:16:35.029Z.
Quote observation: 2026-09-10T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6f8f994af4aaa9bb065f905e04ec16db7bce97ffa2c6125b70ce48a394fdc658
PEG RATIO
N/A
Medtronic plc
Market Cap
$117.28B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Medtronic plc (MDT) | $117.28B | N/A |
| CVS Health Corp. (CVS)vs › | $121.58B | N/A |
| Intuitive Surgical, Inc. (ISRG)vs › | $127.34B | N/A |
| Bristol-Myers Squibb Company (BMY)vs › | $130.22B | N/A |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.60B | N/A |
| Stryker Corporation (SYK)vs › | $103.51B | N/A |
| McKesson Corporation (MCK)vs › | $103.13B | N/A |
| Sanofi (SNY)vs › | $102.58B | N/A |
| GSK plc (GSK)vs › | $96.41B | N/A |
| Danaher Corporation (DHR)vs › | $141.00B | N/A |
PEG Ratio
N/A
P/E Ratio
22.6
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute